Am J Dermatopathol

1. REGMI A, Parra O, Ma W, LeBlanc RE, et al
   Evaluating the Diagnostic Concordance of MyPath Melanoma Assay and PRAME Immunohistochemistry in Challenging Melanocytic Lesions.
   Am J Dermatopathol. 2025 Aug 28. doi: 10.1097/DAD.0000000000003018.
   

   >> Share

   
   
2. HIRAI I, Walker JL, Rubin AI, Chu EY, et al
   CRTC1::TRIM11 Cutaneous Tumor Mimicking Primary Dermal Melanoma: Case Report With Literature Review.
   Am J Dermatopathol. 2025 Aug 26. doi: 10.1097/DAD.0000000000003108.
   

   >> Share

   
   
3. ADDO AK, Beydoun HM, Jeyakumar JE, Olivares S, et al
   The Morphologic Spectrum of NF Mutated Desmoplastic Melanocytic Neoplasms.
   Am J Dermatopathol. 2025 Aug 6. doi: 10.1097/DAD.0000000000003056.
   

   >> Share

   
   
4. MUJEB A, Paez-Garcia MS, Musolff N, Tchack M, et al
   Significance of Sectioning (Breadloafing) the Entire Skin Tissue When Pathology Does Not Match Clinical Appearance.
   Am J Dermatopathol. 2025 Jun 26. doi: 10.1097/DAD.0000000000003046.
   

   >> Share

   
   

   
   Ann Surg Oncol

5. STOFF R, Block MS, Hieken TJ
   ASO Author Reflections: Is PET/CT Response Assessment After Neoadjuvant Systemic Therapy for Stage III Melanoma Enough?
   Ann Surg Oncol. 2025 Aug 29. doi: 10.1245/s10434-025-18276.
   

   >> Share

   
   
6. VAN AKKOOI A, Ariyan C, Moncrieff M
   Melanoma Great Debate: Targeted Versus Complete Nodal Dissection Following Neoadjuvant Therapy for Melanoma: Is it Time to Push Forward or Hold Off on Continued De-Escalation of Surgery?
   Ann Surg Oncol. 2025 Aug 29. doi: 10.1245/s10434-025-18163.
   

   >> Share

   
   
7. STOFF R, Yalon M, Thorpe MP, Flotte TJ, et al
   Accuracy of PET-CT to Assess the Extent of Nodal Disease in Patients with Clinical Stage III Melanoma Following Neoadjuvant Treatment.
   Ann Surg Oncol. 2025 Aug 26. doi: 10.1245/s10434-025-18191.
   

   >> Share

   
   

   
   Anticancer Res

8. BRUNNER AS, Haddad S, Weise JJ, Wagenpfeil S, et al
   Malignant Melanoma: The Relationship Between Sunscreen Use and Cancer Risk - A Systematic Review and Meta-analysis.
   Anticancer Res. 2025;45:3595-3603.
   

   >> Share

   
   

   
   J Immunol

9. TANEGASHIMA K, Esashi E, Ishida K, Kotaki A, et al
   CXCL14 is an essential modulator of TLR9 agonist-induced antitumor immune responses.
   J Immunol. 2025;214:2076-2086.
   

   >> Share

   
   

   
   J Surg Oncol

10. KING A, Brandts-Longtin O, Somayaji C, McDonald JT, et al
    Impact of Social Determinants on Melanoma Outcomes in Canada: A Single-Centre Retrospective Study.
    J Surg Oncol. 2025 Aug 28. doi: 10.1002/jso.70069.
    

    >> Share

    
    

    
    Melanoma Res

11. ZHU JJ, Sahoo A, Song JJ, Vangala VNP, et al
    A high range of intrinsic disorder values for tumor resident, T-cell receptor beta V-complementarity determining region 3-J amino acid sequence assemblies correlates with better melanoma outcomes.
    Melanoma Res. 2025 Aug 29. doi: 10.1097/CMR.0000000000001061.
    

    >> Share

    
    
12. DE GIORGI V, Fazzari F, Cecchi G, Perillo G, et al
    Multiple melanoma, ichthyosis, and juvenile cataracts in a patient with a germline mutation in CDKN2A: pure coincidence or related association?
    Melanoma Res. 2025;35:367-368.
    

    >> Share

    
    
13. XUE GR, Clark M, Slaven JE, Que SKT, et al
    Rurality as a predictor of melanoma stage and treatment in Indiana: a retrospective cohort study.
    Melanoma Res. 2025;35:366-367.
    

    >> Share

    
    
14. ACAR FP, Acar C, Yuksel HC, Sahin G, et al
    Integrating neutrophils, lymphocytes and eosinophils: development and validation of the NLE Index in ICI-treated metastatic melanoma.
    Melanoma Res. 2025 Aug 29. doi: 10.1097/CMR.0000000000001060.
    

    >> Share

    
    

    
    Nat Med

15. KENDRA KL, Bellasea SL, Eroglu Z, Hu-Lieskovan S, et al
    Publisher Correction: Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial.
    Nat Med. 2025 Aug 26. doi: 10.1038/s41591-025-03975.
    

    >> Share

    
    

    
    PLoS One

16. WANG H, Zhang Y, Zhang Y, Zhao X, et al
    SpaVGN: A hybrid deep learning framework for high-resolution spatial transcriptomics data reconstruction and spatial domain identification.
    PLoS One. 2025;20:e0329122.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share